cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Arcturus Therapeutics Holdings Inc
27 own
17 watching
Current Price
$27.17
$0.17
(0.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
721.5M
52-Week High
52-Week High
33.8
52-Week Low
52-Week Low
11.7
Average Volume
Average Volume
0.23M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization721.5M
icon52-Week High33.8
icon52-Week Low11.7
iconAverage Volume0.23M
iconDividend Yield--
iconP/E Ratio--
What does the Arcturus Therapeutics Holdings Inc do?
Arcturus Therapeutics is developing a portfolio of mRNA therapeutics for treatment of diseases with unmet medical needs. Our hope and vision are to build transformative, life-changing medicines for patients and their families. Our team has extensive experience in the discovery and development of mRNA medicines, as well as design and utilization of lipid-mediated drug delivery systems. This combination of in-house expertise, innovative spirit, and passion for what we do, uniquely position us to catalyze the next generation of mRNA medicines.
Read More
How much money does Arcturus Therapeutics Holdings Inc make?
News & Events about Arcturus Therapeutics Holdings Inc.
Ticker Report
1month ago
Sumitomo Mitsui Trust Holdings Inc. reduced its holdings in shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT Get Rating) by 0.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,449,060 shares of ...
Market News Video
3 months ago
In trading on Tuesday, shares of Arcturus Therapeutics Holdings Inc (ARCT) crossed below their 200 day moving average of 17.41, changing hands as low as 17.40 per share. Arcturus Therapeutics Holdings Inc shares are currently trading off about 3.5% on the day...
Business Wire
3 months ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Arcturus Therapeutics, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today...
Business Wire
5 months ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that the...
Business Wire
5 months ago
Arcturus Therapeutics Holdings Inc. (the Company, Arcturus, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, today announced that is has...
Frequently Asked Questions
Frequently Asked Questions
What is Arcturus Therapeutics Holdings Inc share price today?
plus_minus_icon
Can Indians buy Arcturus Therapeutics Holdings Inc shares?
plus_minus_icon
How can I buy Arcturus Therapeutics Holdings Inc shares from India?
plus_minus_icon
Can Fractional shares of Arcturus Therapeutics Holdings Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Arcturus Therapeutics Holdings Inc stocks?
plus_minus_icon
What is today’s traded volume of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What is today’s market capitalisation of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Arcturus Therapeutics Holdings Inc?
plus_minus_icon
What percentage is Arcturus Therapeutics Holdings Inc down from its 52-Week High?
plus_minus_icon
What percentage is Arcturus Therapeutics Holdings Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$27.17
$0.17
(0.63%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Calliditas Therapeutics AB
Calliditas Therapeutics AB
$17.84
$0.04 (0.22 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$24.22
$0.43 (1.81 %)
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
$17.61
$0.19 (1.09 %)
Avid Bioservices Inc
Avid Bioservices Inc
$15.09
$-0.12 (-0.79 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Calliditas Therapeutics AB
Calliditas Therapeutics AB
$17.84
$0.04 (0.22 %)
Bicycle Therapeutics PLC
Bicycle Therapeutics PLC
$24.22
$0.43 (1.81 %)
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
$17.61
$0.19 (1.09 %)
Avid Bioservices Inc
Avid Bioservices Inc
$15.09
$-0.12 (-0.79 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00